Your browser doesn't support javascript.
loading
Elucidation of pathways driving asthma pathogenesis: development of a systems-level analytic strategy.
Walker, Michael L; Holt, Kathryn E; Anderson, Gary P; Teo, Shu Mei; Sly, Peter D; Holt, Patrick G; Inouye, Michael.
Afiliación
  • Walker ML; Medical Systems Biology, Department of Pathology, The University of Melbourne , Parkville, VIC , Australia.
  • Holt KE; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne , Melbourne, VIC , Australia ; Telethon Kids Institute, The University of Western Australia , West Perth, WA , Australia.
  • Anderson GP; Department of Pharmacology and Therapeutics, Lung Health Research Centre, The University of Melbourne , Melbourne, VIC , Australia.
  • Teo SM; Medical Systems Biology, Department of Pathology, The University of Melbourne , Parkville, VIC , Australia ; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne , Melbourne, VIC , Australia.
  • Sly PD; Queensland Children's Medical Research Institute, The University of Queensland , Brisbane, QLD , Australia.
  • Holt PG; Telethon Kids Institute, The University of Western Australia , West Perth, WA , Australia ; Queensland Children's Medical Research Institute, The University of Queensland , Brisbane, QLD , Australia.
  • Inouye M; Medical Systems Biology, Department of Pathology, The University of Melbourne , Parkville, VIC , Australia ; Telethon Kids Institute, The University of Western Australia , West Perth, WA , Australia ; Medical Systems Biology, Department of Microbiology and Immunology, The University of Melbourne , P
Front Immunol ; 5: 447, 2014.
Article en En | MEDLINE | ID: mdl-25295037
Asthma is a genetically complex, chronic lung disease defined clinically as episodic airflow limitation and breathlessness that is at least partially reversible, either spontaneously or in response to therapy. Whereas asthma was rare in the late 1800s and early 1900s, the marked increase in its incidence and prevalence since the 1960s points to substantial gene × environment interactions occurring over a period of years, but these interactions are very poorly understood (1-6). It is widely believed that the majority of asthma begins during childhood and manifests first as intermittent wheeze. However, wheeze is also very common in infancy and only a subset of wheezy children progress to persistent asthma for reasons that are largely obscure. Here, we review the current literature regarding causal pathways leading to early asthma development and chronicity. Given the complex interactions of many risk factors over time eventually leading to apparently multiple asthma phenotypes, we suggest that deeply phenotyped cohort studies combined with sophisticated network models will be required to derive the next generation of biological and clinical insights in asthma pathogenesis.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2014 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2014 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Suiza